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Purpose: To investigate the association between common infections and post-stroke demen-
tia in a UK population-based cohort.
Materials and Methods: A total of 60,392 stroke survivors (51.2% male, median age 74.3 
years, IQR 63.9–82.4 years) were identified using primary care records from the Clinical 
Practice Research Datalink (CPRD) linked to Hospital Episode Statistics (HES) with no 
history of dementia. Primary exposure was any GP-recorded infection (lower respiratory 
tract infection (LRTI), urinary tract infection (UTI) requiring antibiotics, skin and soft tissue 
infection requiring antibiotics) occurring after stroke. The primary outcome was incident all- 
cause dementia recorded in primary care records. In sensitivity analyses, we restricted to 
individuals with linked hospital records and expanded definitions to include ICD-10 coded 
hospital admissions. We used multivariable Cox regression to investigate the association 
between common infections and dementia occurring from 3 months to 5 years after stroke.
Results: Of 60,392 stroke survivors, 20,969 (34.7%) experienced at least one infection and 
overall 4512 (7.5%) developed dementia during follow-up. Early dementia (3 months to 1-year 
post-stroke) risk was increased in those with at least one GP-recorded infection (HR 1.44, 95% 
CI 1.21–1.71), with stronger associations when hospitalised infections were included (HR 1.84, 
95% CI 1.58–2.14). Late dementia (1–5 years) was only associated with hospitalised, but not 
with GP-recorded, infections.
Conclusion: There was evidence of an association between common infections and post- 
stroke dementia, strongest in the 3–12 months following stroke. Better understanding of this 
relationship could help inform knowledge of pathways to dementia post-stroke and targeting 
of preventive interventions.
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Introduction
There are over 1.2 million stroke survivors in the UK,1 where stroke is the 
commonest cause of complex disability. Cognitive problems contribute substan-
tially to post-stroke disability, and while physical impairments will often improve 
after stroke, cognitive function may worsen with time. The incidence of post-stroke 
dementia typically ranges from 7–20% in community-based studies, but may reach 
40% in hospital-based studies.2 Comparisons between studies are limited by differ-
ing definitions and study populations.
Risk factors for post-stroke dementia include demographic factors (older age, 
female sex, non-White ethnicity), existing cognitive decline, location and type of 
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stroke, as well as the presence of small vessel disease or 
cortical atrophy on neuroimaging.2–4 Delirium and early 
seizures5 after stroke are associated with dementia risk,5,6 
although these factors suggest increased stroke severity, 
itself a risk factor for post-stroke dementia. The role of 
common infections in dementia risk is debated. Infections 
could act through systemic inflammatory pathways to trig-
ger a disordered microglial response in the aged brain.7 
While infections in stroke survivors may indicate a more 
severe stroke, they also occur after mild strokes. It is 
unclear whether type, frequency or severity of infections 
affects dementia risk.
Better understanding of the relationship between infec-
tions and dementia in the post-stroke setting will help to 
inform development and targeting of interventions to preserve 
cognitive function after stroke. We therefore aimed to investi-
gate the association between common infections and post- 
stroke dementia in a UK population cohort using linked health 
data.
Materials and Methods
Data Sources and Study Design
We conducted a cohort study using the Clinical Practice 
Research Datalink (CPRD). CPRD Gold contains anon-
ymised GP records of Read-coded diagnoses, investiga-
tions, prescriptions and referrals, patient demographics and 
registration information. Covering around 8% of the UK 
population, it is broadly representative by age, gender, 
ethnicity and mortality.8 Around 75% of English CPRD 
practices are linked to Hospital Episode Statistics (HES). 
The HES Admitted Patient Care database contains ICD-10 
coded records of admissions to all NHS hospitals in 
England from 1997.9
Study Population
We included adults aged ≥40 years who survived an inci-
dent first stroke occurring from 01/01/2005-31/12/2016, 
with at least 1 year of follow-up prior to stroke. Stroke 
was defined as the first record of any stroke type (ischae-
mic, haemorrhagic or unspecified) in CPRD or HES 
according to codelists developed and refined with clini-
cians. Stroke-specific diagnostic codes in EHRs have 
a high validity (positive predictive value≥90%).10 We 
excluded individuals with dementia before stroke and 
those who died or had a new dementia record in the 3 
months after stroke.
Definition of Exposure and Outcome
The primary exposure was GP-recorded infection occur-
ring after stroke, defined as lower respiratory tract infec-
tion (LRTI), urinary tract infection (UTI) treated with 
antibiotics or skin/soft tissue infection (SSTI) treated 
with antibiotics. An algorithm for identifying infections 
that built upon existing codelists11–13 was developed and 
reviewed by two practising clinicians (appendix 1). 
Prescription data was used to identify antibiotics given 
on the day of infection. Exposure status was time- 
varying, so patients contributed person time to the unex-
posed category until exposure to an infection, at which 
point they contributed person time to the exposed cate-
gory. In sensitivity analyses of patients with linked hospi-
tal data, the exposure definition was expanded to include 
ICD-10 coded infections occurring in hospital (an infec-
tion code in any position in the record) as well as com-
munity-acquired infections resulting in hospitalisation (an 
infection recorded as the primary diagnosis). In secondary 
analyses, we explored the effects of number and type of 
infections, with multiple codes occurring within 28 days 
considered to relate to the same infectious episode.
The primary outcome was all-cause dementia, identi-
fied through clinical Read codes in CPRD (or ICD-10 
codes in HES for analyses restricted to those with linked 
data) dated from the first record (appendix 2). Dementia 
was divided into early post-stroke dementia (3 months to 
1 year) and late post-stroke dementia (1 to 5 years). We 
focused on dementia occurring from 3 months after stroke 
to avoid misclassifying delirium or other reversible cogni-
tive changes associated with stroke as dementia.2 Patients 
whose first dementia code suggested prevalent (rather than 
incident) dementia were excluded.
Definition of Covariates
We extracted data on age and sex, and identified cate-
gories of ethnicity from CPRD and HES data using an 
approach previously described.14,15 Socio-economic sta-
tus was assessed at practice level using quintiles of the 
Index of Multiple Deprivation 2016.16 History of depres-
sion, diabetes, myocardial infarction and atrial fibrillation 
before stroke was defined using CPRD clinical diagnostic 
codes. Use of statins, blood-pressure lowering medica-
tion, and immunosuppressant medication in the two years 
prior to the stroke was identified from CPRD prescription 
records. Baseline alcohol use, smoking status and the 
nearest BMI measurement prior to stroke were also 
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taken from CPRD. Prescription of an anti-platelet agent 
within 90 days of stroke was identified from CPRD 
prescription records. We identified new depression diag-
noses by depression Read codes following stroke, in 
patients not coded with depression in the two years 
prior to stroke. Second or subsequent strokes were iden-
tified using ICD-10 codes in the primary diagnosis field 
in HES, with repeated stroke codes within 28 days con-
sidered part of the same episode. We did not consider 
repeated CPRD stroke codes as second episodes, as mul-
tiple GP consultations in the post-stroke period may 
include stroke codes but are unlikely to represent acute 
events.
Statistical Analysis
Follow-up began at 3 months after stroke and ended at the 
earliest of incident dementia, death, transfer out, practice 
final data collection date, 5 years post-stroke or 31/12/ 
2016. We described the study population at time of stroke 
and compared characteristics by exposure and outcome 
variables. We calculated rates of early and late dementia 
per 1,000 person years at risk (PYAR) with 95% confi-
dence intervals for each exposure category. We developed 
multivariable Cox regression models to assess the relation-
ship between the time-updated primary exposure any GP- 
recorded infection and early and late dementia using 
CPRD data only, first adjusting for age and sex, and then 
including additional covariates. We carried out several 
sensitivity analyses restricted to patients with linked 
CPRD-HES data, which included: 1) repeating the primary 
analysis in patients with linked data to increase ascertain-
ment of dementia; 2) expanding the definition of infection 
to include infections recorded in either GP or hospital 
records (any position), or in GP or hospital records (first 
position only); and 3) repeating all analyses excluding 
infections occurring within 3 months of stroke. We then 
explored the effect of number of infection episodes and 
first infection type. Likelihood ratio tests were used to 
calculate p-values. Analyses were carried out using Stata 
version 15. Analytic code is available at GitHub (https:// 
github.com/CarolineMorton/stroke-infection-research- 
code).
Ethics Statement
This study was approved by CPRD’s Independent 
Scientific Advisory Committee (17_176R) and the 
London School of Hygiene & Tropical Medicine 
Research Ethics Committee (14,319).
Results
Description of Study Cohort
We included 60,392 stroke survivors with a median 2.60 
years (IQR 0.97–4.75) of follow-up (Figure 1). Just over 
half were men (51.2%) with a median age of 74.3 years 
(IQR 63.9–82.4 years). Median consultation frequency 
was 12.3 per year pre-stroke, rising to 24.2 per year after 
stroke. A total of 44,057 GP-recorded infections after 
stroke were identified for 20,969 patients (34.7%), median 
2 infections per person (IQR 1–3). First infections com-
prised 53.6% LRTIs, 33.2% UTIs and 13.1% SSTIs. 
Linked HES data were available for 64.9%. Table 1 
shows study participants’ characteristics overall and by 
infection status.
Overall, 4512 (7.5%) patients developed dementia 3 
months to 5 years post-stroke, of whom 1406 (31.2%) 
developed early dementia (rate 35.13 per 1000 PYAR 
[95% CI 33.34–37.02]) and 3106 (68.8%) developed late 
dementia (rate 25.80 per 1000 PYAR [95% CI 24.91– 
26.72]). Both early and late dementia incidence increased 
with age and was higher in women.
Infections and Early Post-Stroke 
Dementia
Early dementia was more common among those with any 
GP-recorded infection compared to those without (HR 
1.44, 95% CI 1.21–1.71). Restricting to those with linked 
data increased the strength of association (HR 1.53, 95% 
CI 1.28–1.84). Effect estimates were higher again when 
hospitalised infections were included either as a primary 
diagnosis (HR 1.79, 95% CI 1.52–2.11), or as any diag-
nosis (HR 1.84, 95% CI 1.58–2.14): Table 2, appendix 3. 
There was no evidence of effect modification with recur-
rent stroke (p=0.493). Excluding infections in the first 3 
months did not affect results (appendix 4)
Infections and Late Post-Stroke Dementia
For late dementia, while the crude incidence was raised among 
those who had experienced a GP-recorded infection, adjust-
ment for confounders removed any association (HR 1.05, 95% 
CI 0.96–1.16). In the sensitivity analyses restricted to those 
with linked data, there was some evidence that infections were 
associated with late dementia, with stronger effects seen for 
exposure definitions that include hospitalised infections (HR 
1.36, 95% CI 1.23–1.50 for infection as primary diagnosis) 
than for GP-recorded infections (HR 1.10, 95% CI 0.99–1.22) 
(Table 2, appendix 3). Again, there was no evidence of effect 
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modification with recurrent stroke. Excluding infections in the 
first 3 months did not change results.
Number and Type of Infections and 
Post-Stroke Dementia
Increasing number of GP-recorded infections were asso-
ciated with early dementia (LRT for trend: 0.0002), 
although only small numbers had ≥2 infections (Table 3). 
When exposure was expanded to include hospitalised 
infections, there was an upward trend with increasing 
number of infections, although confidence intervals over-
lapped. We saw a strong association between LRTI or UTI 
as first infection and early dementia (HR 1.46, 95% CI 
1.16–1.83, HR 1.61, 95% CI 1.26–2.04 respectively), 
which was not seen for SSTI, though numbers with 
dementia were small (n=22). There was an association 
between an increasing number of GP-recorded infections 
and late dementia (LRT for trend: 0.023), which was 
stronger when hospital infections were included (LRT for 
trend: <0.001). Infection type was not associated with late 
dementia (p=0.272, appendix 5).
Discussion
We showed a 44% increase in early dementia among 
stroke survivors with common infections recorded by the 
GP after adjusting for other factors, in a UK population 
cohort of >60,000 individuals. The association was robust 
to a range of sensitivity analyses and became stronger 
when hospitalisations with infection were included. 
While there was little evidence that GP-recorded infection 
was associated with late dementia, an association was seen 
when infection hospitalisations were included. These find-
ings suggest that better prevention or management of 
common infections following stroke may help to improve 
outcomes including preserving cognitive function, 
although further work is needed to disentangle the effect 
of stroke severity on this relationship.
In our study, 7.5% of patients developed dementia from 
3 months to five years after stroke, which is at the lower 
end of the reported range for post-stroke dementia 
incidence.2,4 This may be due to its population-based 
nature. We also identified dementia diagnoses from routine 
EHRs, in contrast to some other cohort studies which 
conducted universal cognitive testing. While the positive 
Figure 1 Flowchart of study participants.
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Table 1 Characteristics of Study Participarticipants
Total No Infection Any GP-Recorded Infection After Stroke*
0–3 Months 3 Months–1 Year 1–5 Years
Baseline, N (%)
All patients 60,392 (100.0) 39,423 (65.3) 3590 (5.9) 6886 (11.4) 10,493 (17.4)
Mean age (SD) 72.6 (12.7) 71.7 (12.9) 76.4 (11.9) 75.4 (12.1) 72.7 (12.1)
Sex
Male 30,912 (51.2) 21,454 (54.4) 1523 (42.4) 3037 (44.1) 4898 (46.7)
Female 29,480 (48.8) 17,969 (45.6) 2064 (57.6) 3849 (55.9) 5595 (53.3)
Country
England 45,464 (75.6) 29,892 (75.8) 2700 (75.2) 5290 (76.8) 7772 (74.1)
Wales 5736 (9.5) 3616 (9.2) 324 (9.0) 659 (9.6) 1137 (10.8)
Scotland 7075 (11.7) 4767 (12.1) 401 (11.2) 692 (10.0) 1217 (11.6)
Northern Ireland 1927 (3.2) 1148 (2.9) 165 (4.6) 247 (3.6) 367 (3.5)
Ethnicity
White 43,526 (72.1) 28,300 (71.8) 2580 (71.9) 5069 (73.6) 7577 (72.2)
South Asian 885 (1.5) 593 (1.5) 50 (1.4) 88 (1.3) 154 (1.5)
Black 543 (0.9) 404 (1.0) 19 (0.5) 47 (0.7) 73 (0.7)
Other/Mixed 520 (0.9) 392 (1.0) 16 (0.5) 46 (0.7) 66 (0.6)
Unknown 14,918 (24.7) 9734 (24.7) 925 (25.7) 1636 (23.8) 2623 (25.0)
Local area deprivation score (quintiles)
1 (= least deprived) 10,787 (17.9) 6844 (17.4) 708 (19.7) 1277 (18.5) 1958 (18.7)
2 10,638 (17.6) 6935 (17.6) 634 (17.7) 1228 (17.8) 1841 (17.6)
3 12,564 (20.8) 8252 (20.9) 711 (19.8) 1447 (21.0) 2154 (20.5)
4 12,876 (21.3) 8772 (22.3) 711 (19.8) 1293 (18.8) 2100 (20.0)
5 (= most deprived) 13,527 (22.4) 8620 (21.9) 826 (23.0) 1641 (23.8) 2440 (23.3)
Smoking status
Never 21,273 (36.0) 14,026 (36.6) 1221 (34.2) 2360 (34.9) 3666 (35.1)
Past 25,936 (44.0) 16,396 (42.8) 1729 (48.4) 3156 (46.7) 4694 (45.0)
Current 11,884 (20.0) 7899 (20.6) 623 (17.4) 1249 (18.5) 2073 (19.9)
Alcohol Use (n=54,316)
None 15,287 (28.1) 9343 (26.7) 1067 (32.4) 2038 (32.8) 2839 (29.1)
Current 39,029 (71.9) 25,708 (73.3) 2231 (67.7) 4176 (67.2) 6914 (70.9)
BMI category
Underweight 1645 (3.0) 1031 (2.9) 132 (4.0) 213 (3.4) 269 (2.7)
Normal Weight 18,455 (33.9) 12,007 (34.3) 1172 (35.5) 2124 (34.0) 3152 (32.1)
Overweight 20,359 (37.4) 13,297 (38.0) 1180 (35.7) 2231 (35.7) 3651 (37.2)
Obese 13,941 (25.6) 8703 (24.8) 820 (24.8) 1684 (26.9) 2734 (27.9)
Clinical conditions
History of Diabetes 8978 (14.9) 5431 (13.8) 683 (19.0) 1224 (17.8) 1640 (15.6)
History of Atrial fibrillation 7995 (13.2) 4704 (11.9) 609 (17.0) 1186 (17.2) 1496 (14.3)
History of Myocardial Infarction 4831 (8.0) 2897 (7.4) 366 (10.2) 647 (9.4) 921 (8.8)
History of Depression 3697 (6.1) 2050 (5.2) 348 (9.7) 564 (8.2) 735 (7.0)
Use of medication in 2 years prior to stroke
Anti-hypertensive 35,781 (59.3) 22,077 (56.0) 2541 (70.8) 4581 (66.5) 6582 (62.7)
Statin 21,837 (36.2) 13,482 (34.2) 1531 (42.7) 2799 (40.7) 4025 (38.4)
Immunosuppressant 6894 (11.4) 3491 (8.9) 726 (20.2) 1308 (19.0) 1369 (13.1)
(Continued)
Dovepress                                                                                                                                                         Morton et al
Clinical Epidemiology 2020:12                                                                                               submit your manuscript | www.dovepress.com                                                                                                                                                                                                                       
DovePress                                                                                                                         
911
Table 2 Rates of Early and Late Post-Stroke Dementia by Infection Status, and Results from Cox Regression Models
Infection Total 
Dementia 
Cases
Total 
Person 
Time
Rate per 1000 
Person Years 
(95% CI)
HR (95% CI)
Crude Sex and Age 
Adjusted
Fully 
Adjusted*
P-value **
Early Dementia
All GP-recorded infections only
No Infection 1145 35,284 32.45 (30.63–34.39) 1 1 1 <0.001
Any Infection 261 4735 55.12 (48.83–62.23) 1.80 (1.57–2.06) 1.44 (1.26–1.65) 1.44 (1.21–1.71)
Restricted 
to patients 
with linked 
HES
GP recorded infections only
No Infection 877 22,657 38.71 (36.23–41.36) 1 1 1 <0.001
Any Infection 214 3011 71.07 (62.16–81.26) 1.93 (1.66–2.25) 1.57 (1.34–1.82) 1.53 (1.28–1.84)
GP recorded and hospital recorded infections
No Infection 581 19,052 30.50 (28.11–33.08) 1 1 1 <0.001
Any Infection 510 6616 77.08 (70.67–84.07) 2.59 (2.30–2.91) 1.99 (1.76–2.24) 1.84 (1.58–2.14)
GP recorded and hospital recorded infections where infection was primary diagnosis
No Infection 775 21,778 35.59 (33.17–38.18) 1 1 1 <0.001
Any Infection 316 3891 81.22 (72.74–90.69) 2.40 (2.11–2.74) 1.91 (1.67–2.18) 1.79 (1.52–2.11)
Late Dementia
All GP recorded infections only
No Infection 2009 84,239 23.85 (22.83–24.92) 1 1 1 0.296
Any Infection 1097 36,150 30.35 (28.60–32.20) 1.30 (1.20–1.40) 1.07 (0.99–1.15) 1.05 (0.96–1.16)
Restricted 
to patients 
with linked 
HES
GP recorded infections only
No Infection 1562 53,194 29.36 (27.94–30.86) 1 1 1 0.065
Any Infection 847 22,121 38.29 (35.29–40.96) 1.31 (1.21–1.43) 1.09 (1.00–1.19) 1.10 (0.99–1.22)
GP recorded and hospital recorded infections
No Infection 955 43,680 21.86 (20.52–23.30) 1 1 1 <0.001
Any Infection 1454 31,635 45.96 (43.66–48.39) 2.13 (1.96–2.31) 1.66 (1.53–1.80) 1.50 (1.35–1.66)
GP recorded and hospital recorded infections where infection was primary diagnosis
No Infection 1269 49,488 25.64 (24.27–27.09) 1 1 1 <0.001
Any Infection 1140 25,827 44.14 (41.65–46.78) 1.75 (1.61–1.90) 1.40 (1.29–1.52) 1.36 (1.23–1.50)
Notes: *Adjusted for age, sex, country, consultation frequency, ethnicity, deprivation, alcohol, smoking, BMI, pre-morbid conditions, pre-stroke use of medication, anti- 
coagulant prescribing post stroke and depression (pre and post stroke). **Likelihood ratio test.
Table 1 (Continued).  
Total No Infection Any GP-Recorded Infection After Stroke*
0–3 Months 3 Months–1 Year 1–5 Years
Post stroke, N (%)
Antiplatelet use within 90 days 37,148 (61.5) 23,792 (60.4) 2341 (65.2) 4223 (61.3) 6792 (64.7)
New depression post stroke± 5457 (9.6) 2885 (7.7) 383 (11.8) 821 (13.0) 1368 (14.0)
Notes: *Defined as any of lower respiratory tract infection, urinary tract infection with antibiotics, or skin/soft tissue infection with antibiotics. Timing is categorised by first infection 
after stroke. ± N=56,695.
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Table 3 Rates of Dementia by Number of Infections, and Results from Cox Regression Models
Infection Total 
Dementia 
Cases
Total 
Person 
Time
Rate per 1000 
Person Years (95% 
CI)
HR (95% CI) P-value **
Crude Sex and Age 
Adjusted
Fully 
Adjusted*
Early Dementia
All GP-recorded infections only
No Infection 1145 35,284 32.45 (30.63–34.39) 1 1 1 0.0002
1 infection 211 3851 54.79 (47.88–62.71) 1.77 (1.52–2.05) 1.44 (1.24–1.67) 1.48 (1.23–1.78)
2 or more 
infections
50 884 56.57 (42.87–74.63) 1.94 (1.46–2.58) 1.43 (1.07–1.90) 1.26 (0.88–1.82)
Restricted to 
patients with 
linked HES
GP recorded infections only
No Infection 877 22,658 38.71 (36.23–41.36) 1 1 1 <0.001
1 infection 175 2453 71.35 (61.52–82.74) 1.92 (1.63–2.26) 1.58 (1.34–1.86) 1.59 (1.31–1.92)
2 or more 
infections
39 559 69.83 (51.02–95.58) 1.99 (1.44–2.75) 1.50 (1.09–2.07) 1.31 (0.89–1.94)
GP recorded and all hospital infections
No Infection 581 19,052 30.50 (28.11–33.08) 1 1 1 <0.001
1 infection 305 4673 65.28 (58.35–73.03) 2.17 (1.89–2.49) 1.69 (1.47–1.95) 1.57 (1.32–1.87)
2 or more 
infections
205 1944 105.46 (91.97–120.93) 3.65 (3.11–4.28) 2.71 (2.31–3.19) 2.53 (2.06–3.11)
GP recorded and primary hospital infections
No Infection 775 21,778 35.59 (33.17–39.18) 1 1 1 <0.001
1 infection 230 3051 75.38 (66.24–85.78) 2.21 (1.90–2.56) 1.78 (1.54–2.07) 1.69 (1.41–2.02)
2 or more 
infections
86 840 102.43 (82.92–126.54) 3.18 (2.54–3.99) 2.38 (1.90–2.99) 2.16 (1.64–2.84)
Late Dementia
All GP recorded infections only
No Infection 2009 84,239 23.85 (22.83–24.92) 1 1 1 0.023
1 infection 572 20,900 27.37 (25.22–29.71) 1.16 (1.06–1.28) 1.00 (0.91–1.10) 1.01 (0.90–1.14)
2 infections 232 7729 30.02 (26.39–34.14) 1.29 (1.12–1.48) 1.03 (0.90–1.18) 1.03 (0.87–1.21)
3 infections 126 3402 37.03 (31.10–44.10) 1.60 (1.34–1.92) 1.23 (1.03–1.47) 1.16 (0.93–1.45)
4 infections 61 1668 36.58 (28.46–47.01) 1.59 (1.23–2.06) 1.20 (0.93–1.54) 0.97 (0.69–1.35)
5 or more 
infections
106 2451 43.24 (35.74–52.31) 1.91 (1.56–2.32) 1.41 (1.16–1.72) 1.40 (1.11–1.77)
Restricted to 
patients with 
linked HES
GP recorded infections only
No Infection 1562 53,194 29.36 (27.94–30.86) 1 1 1 0.002
1 infection 428 12,783 33.48 (30.46–36.81) 1.15 (1.03–1.28) 1.00 (0.90–1.12) 1.05 (0.93–1.19)
2 infections 187 4762 39.27 (34.03–45.32) 1.35 (1.16–1.58) 1.09 (0.93–1.27) 1.05 (0.88–1.26)
3 infections 100 2107 47.46 (39.01–57.74) 1.65 (1.34–2.02) 1.27 (1.03–1.55) 1.25 (0.99–1.57)
4 infections 44 1009 43.61 (32.45–58.60) 1.52 (1.12–2.05) 1.14 (0.85–1.55) 1.02 (0.72–1.45)
5 or more 
infections
88 1460 60.28 (48.91–74.28) 2.11 (1.69–2.62) 1.57 (1.26–1.95) 1.55 (1.22–1.97)
GP recorded and all hospital infections
No Infection 955 43,680 21.86 (20.52–23.30) 1 1 1 <0.001
1 infection 606 16,527 36.67 (33.86–39.71) 1.70 (1.53–1.88) 1.40 (1.26–1.55) 1.28 (1.13–1.45)
2 infections 366 7220 50.69 (45.75–56.16) 2.37 (2.10–2.67) 1.78 (1.58–2.01) 1.70 (1.47–1.96)
3 infections 186 3480 53.45 (46.29–61.71) 2.52 (2.15–2.95) 1.86 (1.59–2.18) 1.53 (1.26–1.86)
(Continued)
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predictive value of a dementia diagnosis in EHR data is 
generally high (>75%), sensitivity is lower.17 In addition, 
our study excluded dementia diagnoses in the first 3 
months after stroke as acute brain injury post-stroke can 
temporarily affect cognition.
Estimates of the risk of post-stroke infections vary 
depending on study population, timing and methods 
used to identify infections. In a meta-analysis of 87 
studies assessing infection in the acute phase after 
stroke, the pooled infection rate was 30% (95% CI 
24% to 36%),18 in contrast to our study which found 
that 6% of patients experienced an infection in the first 
3 months. However, the meta-analysis included patients 
with all premorbid conditions and those who died 
shortly after stroke, whereas for inclusion in our 
study, patients had to survive for at least 3 months 
post-stroke and have no history of dementia. In this 
population of stroke survivors, we showed that 34.7% 
had an infection up to 5 years after stroke. Validation 
studies show that 93% of infections recorded in EHRs 
can be confirmed by an additional information 
source.19
Strengths and Limitations of the Study
Using routinely collected electronic health data increases 
the power and generalisability of findings as well as 
overcoming some methodological difficulties that may 
hamper traditional cohort studies of post-stroke dementia, 
such as ascertainment bias. In addition, there is good 
capture of demographic and clinical covariates, while 
completeness and accuracy of diagnoses were enhanced 
through linkage to hospital data. Diagnoses of stroke, 
infections and dementia all demonstrate a high positive 
predictive value in EHRs. Although only around two 
thirds of dementia patients have a formal diagnosis in 
their primary care record,20 as our study population all 
had incident strokes and visited the GP regularly, any 
misclassification of dementia is unlikely to be differential 
by exposure status. While it is possible that reversible 
confusion, e.g., induced by infections or persisting 
beyond three months of stroke could be misclassified as 
dementia, usual clinical practice is to assess trajectories 
of cognitive change and functional status over time. In 
addition, current guidance in England and Wales recom-
mends referral to a specialist dementia diagnostic service 
such as a memory clinic if dementia is suspected after 
reversible causes of cognitive change have been 
investigated,21 so this seems less likely. Nevertheless, 
we cannot exclude some degree of reverse causality, in 
which individuals with early undiagnosed dementia may 
develop more infections after stroke, perhaps through 
poorer nutritional status or self-care, especially as pre- 
stroke cognition is not routinely captured in EHRs.
In our analysis we were unable to assess severity and 
location of stroke, which may be predictors of infection 
and are linked to dementia risk.3 We did however limit to 
those who survived for at least three months which would 
exclude the most severe strokes. Other studies have shown 
that both immediate and later infections after stroke are 
associated with poorer long-term functional outcomes and 
Table 3 (Continued). 
Infection Total 
Dementia 
Cases
Total 
Person 
Time
Rate per 1000 
Person Years (95% 
CI)
HR (95% CI) P-value **
Crude Sex and Age 
Adjusted
Fully 
Adjusted*
4 infections 110 1774 62.03 (51.45–74.77) 2.94 (2.41–3.59) 2.09 (1.71–2.55) 1.88 (1.48–2.38)
5 or more 
infections
186 2634 70.61 (61.16–81.53) 3.41 (2.90–4.00) 2.44 (2.08–2.86) 2.22 (1.84–2.70)
GP recorded and primary hospital infections
No Infection 1269 49,488 25.64 (24.27–27.09) 1 1 1 <0.001
1 infection 539 14,345 37.58 (34.53–40.80) 1.49 (1.34–1.64) 1.25 (1.13–1.38) 1.27 (1.13–1.43)
2 infections 262 5664 46.26 (40.98–52.21) 1.84 (1.61–2.11) 1.44 (1.26–1.65) 1.31 (1.11–1.54)
3 infections 145 2654 54.63 (46.42–64.29) 2.20 (1.85–2.61) 1.66 (1.39–1.97) 1.50 (1.22–1.85)
4 infections 74 1271 58.23 (46.36–73.13) 2.35 (1.86–2.98) 1.71 (1.35–2.17) 1.71 (1.31–2.23)
5 or more 
infections
120 1893 63.39 (53.01–75.81) 2.60 (2.15–3.15) 1.92 (1.58–2.32) 1.86 (1.50–2.32)
Notes: *Adjusted for age, sex, country, consultation frequency, ethnicity, deprivation, alcohol, smoking, BMI, pre-morbid conditions, pre-stroke use of medication, anti- 
coagulant prescribing post-stroke and depression (pre- and post-stroke). **Likelihood ratio test.
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mortality, independent of any effect of stroke severity.22–24 
In addition, our findings remained similar when excluding 
infections occurring in the first 3 months, which are likely 
to be associated with more severe strokes. Only 65% of 
participants had linked data so contributed to the analyses 
of hospital infections, but these additional sensitivity ana-
lyses confirmed findings for the whole cohort. Therefore, 
while over diagnosis of infections in primary care due to 
lack of diagnostic tests could lead to misclassification of 
exposure, this is unlikely to have significantly affected 
findings. Some potential confounders such as education 
are not recorded in routine health data, although we used 
IMD level as a proxy. Nevertheless, there may be other 
relevant unmeasured factors such as dysphagia after stroke 
or urinary catheterization, which could be linked to stroke 
severity and also to likelihood of infections. We used data 
from after the introduction of the Quality and Outcomes 
Framework in 2004, which markedly improved the com-
pleteness of primary care recording.8
Mechanisms
Impaired immunity is common after stroke and increases 
susceptibility to infections.25 Systemic inflammation, which 
impacts the progression of cardiovascular disease, could 
partly explain the association between infections and post- 
stroke dementia.26,27 Major infection can also result in 
inflammatory brain changes, for example, in multiple 
sclerosis about one third of all relapses are associated with 
a systemic infection, with increased immune activation seen 
on brain imaging.28 Infections are also well-recognised to 
contribute to delirium, which is present in about 20% of all 
general hospital inpatients, increasing to over 30% in those 
>80 years old and 27% in stroke patients,29,30 and is an 
independent risk factor for dementia.31
Conclusion
Our study found evidence of an association between com-
mon infections and post-stroke dementia in a large cohort 
of UK stroke survivors using linked routine health data. 
Future research to investigate this relationship would ben-
efit from including markers of stroke severity and repeated 
standardised measures of cognition to investigate trajec-
tories of a broader range of cognitive outcomes over time. 
Better understanding of this relationship will help to 
inform the development and targeting of interventions 
such as vaccines or early antibiotic use to prevent and 
treat infections after stroke and perhaps thereby preserve 
cognitive function.
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